1 (877) DEVANA-2 info@devanasolutions.com

About Devana Solutions®:

A Company on a Mission to Reduce the Cost of Healthcare and Cure Disease through Technology 

We connect the best Research Sites with Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® is a SaaS provider driven by a core belief that data transparency through technology is key in selection of the top performing research sites to align with pharmaceutical Sponsors and CROs in an effort to reduce drug cost and cure diseases. Devana Solutions® offers two platforms, IGNITE FOR SITES and MATCH PERFORMANCE, to provide data, aggregation and access to drug development stakeholders.


At Devana Solutions®, our unwavering commitment to this core belief inspires the cloud-based technology platforms we build, license and support.

Drug sponsors & CROs must find and select the best research sites – those that consistently recruit, screen and enroll more patients, faster and safely while gathering clean, accurate data on a drug’s safety and effectiveness – to REDUCE CLINICAL TRIAL CYCLE TIME and drug development costs.

MATCH PERFORMANCE reduces site selection risk for CROs and sponsors by providing full transparency into a site or site network’s historical and real-time performance and timing metrics, improving trial feasibility and performance while reducing clinical trial cycle time and costs.

IGNITE FOR SITES arms investigators and research sites with powerful data to win more study awards in less time. Use the technology to prove your therapeutic strengths and enrollment capabilities by easily reporting and displaying timing and performance metrics to CROs and sponsors.

Gain total transparency in understanding your site’s metrics – both good and bad – and use these centralized business analytics to help your site’s management team improve study performance.

Save valuable time for your site managers by centralizing and automating your contacts, pipeline and document administration to track study leads all the way through trial completion and close out.